Large-scale molecular epidemiological survey of Giardia and Cryptosporidium in Victoria, Australia (2020–2024), reveals novel subtypes and outbreak-associated lineages
Journal of Clinical Microbiology · 13.05.2026 · 64 (5)
DOI: 10.1128/jcm.01558-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Microbiology, erschienen am 13.05.2026. Verfasst von Marielle Babineau und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, The University of Melbo…. Hauptthemen laut MEDLINE: Giardia, Cryptosporidium, Giardiasis, Cryptosporidiosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Education and Training, National Health and Medical Research Council.
Abstract (Originalsprache)
Cryptosporidium and Giardia are major causes of gastrointestinal illness globally. In Australia, cryptosporidiosis is nationally notifiable, yet molecular characterization is not routinely undertaken, limiting outbreak detection, source attribution, and zoonotic risk assessment. This limitation became apparent in 2024, when Australia experienced a 273% increase in cryptosporidiosis notifications, the third-highest rise globally. We conducted a molecular epidemiological investigation of Cryptosporidium and Giardia in fecal samples from humans with gastroenteritis in Victoria, Australia, between 2020 and 2024. Positive samples were sequenced using SSU and gp60 for Cryptosporidium and tpi for Giardia , and parasite load was estimated. Of the 2,330 samples tested, 225 were positive for Cryptosporidium and nine for Giardia . One Giardia sample was identified as sub-assemblage AI, two as AII, and six as assemblage B. Seven Cryptosporidium species and 24 subtypes were identified, including eight novel subtypes. Cryptosporidium hominis predominated (85%), followed by C. parvum and C. meleagridis . Six C. hominis subtypes were detected, three associated with 11 recreational water-linked outbreaks in 2024. Subtypes IaA12R3 and IeA11G3T3 were most frequent, in line with global trends; concordance analysis indicated that at least 52 additional cases were likely linked to outbreaks. Several C. parvum subtypes were identified, including two linked to childcare and camp outbreaks. Novel human-infective subtypes of C. occultus , C. fayeri , and C. meleagridis were also detected. These findings reveal extensive Cryptosporidium diversity in Victoria and highlight the value of molecular surveillance for resolving transmission pathways and informing public health responses. IMPORTANCE Cryptosporidium is a nationally notifiable pathogen in Australia, yet routine subtyping is not performed, limiting the detection of both outbreak-related and sporadic transmission and constraining source attribution. This study represents the first large-scale molecular surveillance of human Cryptosporidium and Giardia infections in southern Australia, including the first molecular epidemiological exploration of the marked increase in cryptosporidiosis observed in 2024. By integrating species, subtype, or assemblage information with epidemiological metadata, we demonstrate substantial Cryptosporidium lineage diversity in symptomatic patients, including multiple novel subtypes and zoonotic transmission. These findings demonstrate the critical value of molecular tools for uncovering hidden transmission, resolving pathways contributing to both sporadic disease and outbreak, and informing targeted public health responses. The findings provide a strong foundation for incorporating routine genotyping into national surveillance systems for parasitic eukaryotic enteropathogens, and the accompanying international comparison of case trends suggests broader transmission dynamics of significant public health relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
- Department of Veterinary Biosciences, Melbourne Veterinary School, The University of Melbourne, Parkville, Victoria, Australia.
- Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
- Department of Health, Melbourne, Victoria, Australia.
- Centre for Pathogen Genomics, The University of Melbourne, Melbourne, Victoria, Australia.
ORCID-Profile: Marielle Babineau, Anson V Koehler, Michelle L Sait, Karolina Mercoulia, Robin B Gasser, Benjamin P Howden
Förderung
- Department of Education and Training
- National Health and Medical Research Council
Zitieren
APA
Babineau, M., Koehler, A. V., Sait, M. L., Mercoulia, K., Dougall, S., McAllister, J., Wong, E., Sherry, N. L., Gasser, R. B., & Howden, B. P. (2026). Large-scale molecular epidemiological survey of Giardia and Cryptosporidium in Victoria, Australia (2020–2024), reveals novel subtypes and outbreak-associated lineages. Journal of Clinical Microbiology, 64(5). https://doi.org/10.1128/jcm.01558-25
Vancouver
Babineau M, Koehler AV, Sait ML, Mercoulia K, Dougall S, McAllister J, et al. Large-scale molecular epidemiological survey of Giardia and Cryptosporidium in Victoria, Australia (2020–2024), reveals novel subtypes and outbreak-associated lineages. Journal of Clinical Microbiology. 2026;64(5). doi:10.1128/jcm.01558-25
BibTeX
@article{Babineau2026,
author = {Babineau, Marielle and Koehler, Anson V and Sait, Michelle L and Mercoulia, Karolina and Dougall, Sally and McAllister, Jane and Wong, Evelyn and Sherry, Norelle L and Gasser, Robin B and Howden, Benjamin P},
title = {Large-scale molecular epidemiological survey of Giardia and Cryptosporidium in Victoria, Australia (2020–2024), reveals novel subtypes and outbreak-associated lineages},
journal = {Journal of Clinical Microbiology},
year = {2026},
volume = {64},
number = {5},
doi = {10.1128/jcm.01558-25}
}
EUVIMED